Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Alzheimer, Headache & Co.: Detecting Neurological Illnesses Better And Earlier
The rapid development of modern neuroimaging has made a decisive improvement in the diagnosis of neurological illnesses. As Professor Filippi notes: "Neuroimaging makes new diagnostic tools available with the potential to quantify the extent of CNS injury, to define the nature of the different pathological substrates of the various CNS affections and to assess the functional changes following tissue damage with the ability to limit the clinical consequences of injury."
generic viagra online
Stinging Insects Can Cause Real Summer Fears But There Are Real Ways To Prevent Them
The term Cnidophobia may be uncommon but what it describes is not. Cnidophobia is the fear of insect stings. Although a "phobia" may seem to be an overreaction to what some consider nuisance pests, homeowners must recognize the health threats associated with stinging insects. The National Pest Management Association (NPMA) reports more than half million people are sent to the emergency room every year due to stinging insects, which is why these summer pests must be addressed efficiently and effectively.
News of the day
Microbial Analysis, Micropatterning Methods Featured In Cold Spring Harbor Protocols
Microbial populations have traditionally been studied in carefully controlled, laboratory-grown cultures. New metagenomic approaches are being developed to study these organisms in environmental or medical samples. The July issue of Cold Spring Harbor Protocols presents a method developed by Holger Daims from the University of Vienna for quantifying populations of microorganisms in a variety of naturally occurring conditions such as plankton samples or biofilms. Use of Fluorescence In Situ Hybridization and the daime Image Analysis Program for the Cultivation-Independent Quantification of Microorganisms in Environmental and Medical Samples combines fluorescent in situ hybridization using rRNA-targeted probes with digital image analysis. The results show an organism"s "biovolume fraction" in a given sample; this indicates the share of biochemical reaction space occupied by the quantified population and can be more relevant ecologically than absolute cell numbers. The article is freely available on the website for Cold Spring Harbor Protocols.
Diagnostics

Indian Authorities Asked To Stop Licensing Artemisinin-Only Malaria Drugs

The Drugs Controller General of India (DCGI) asked state drug licensing authorities to avoid authorizing new licenses for single drug formulations of artemisinin and withdraw existing licences for these types of drugs by the end of this month, livemint.com reports. To prevent drug resistance, the WHO has advised against the use of drugs that only contain artemisinin to treat malaria and recommends using artemsinin in combination with other drugs. "India"s drug advisory body, the drug consultative committee, had in December approved the phasing out of the [artemisinin only] drug[s] from the market," livemint.com writes. H.G. Koshia, the commissioner of the food and drug control administration for the state of Gujarat, said, "The state department has received the last directive in this regard a couple of weeks ago, and we have already informed all existing licence holders to stop manufacturing. The brand recalls from the market is also in progress, though there aren"t many at present." According to livemint.com: "Ipca Laboratories Ltd., Themis Medicare Ltd., Plethico Pharmaceuticals Ltd., GVS Laboratories Ltd., Cipla and Lupin Ltd. are some of the top firms in the domestic anti-malaria market. These are also key suppliers to overseas markets through [the] WHO or direct channels, and most have already stopped making the product following [the] WHO"s warning on single oral therapy using artemisinin and its derivatives." R.B. Smartha, the managing director of Mumbai-based Interlink Marketing Consultancy Pvt. Ltd., said, "The impact of the DCGI order would not be big for the industry as the market for oral single formulation of artemisinin derivatives has already shrunk" (Pandeya/Unnikrishnan, 7/22). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009